CCR2-dependent monocyte-derived macrophages resolve inflammation and restore gut motility in postoperative ileus

Giovanna Farro1, Michelle Stakenborg1, Pedro J Gomez-Pinilla1

  • 1Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium.

Gut
|June 16, 2017
PubMed
Abstract

Insights

Monocytes play a crucial role in recovering gastrointestinal motility after surgery. Targeting monocytes may worsen postoperative ileus (POI), suggesting therapies should enhance macrophage repair functions for better recovery.

Area of Science:

  • Gastroenterology
  • Immunology
  • Surgical Research

Background:

  • Postoperative ileus (POI) is linked to myeloid cell infiltration in the intestinal muscularis externa after abdominal surgery.
  • The precise role of infiltrating monocytes in POI pathogenesis and resolution remains unclear.

Purpose of the Study:

  • To investigate the role of infiltrating monocytes in a murine model of intestinal manipulation (IM)-induced POI.
  • To determine if monocytes mediate tissue damage and dysfunction or aid in gastrointestinal (GI) motility recovery.

Main Methods:

  • Intestinal manipulation (IM) performed in wild-type (WT) and C-C motif chemokine receptor 2 (Ccr2) knockout mice with defective monocyte migration.
  • Assessment of GI transit, inflammation, and immune cell infiltration (neutrophils, monocyte-derived macrophages).
  • Bone marrow reconstitution and treatment with macrophage colony-stimulating factor 1 (M-CSF1) in Ccr2 mice.

Main Results:

  • IM-induced GI transit delay and inflammation were similar in WT and Ccr2 mice initially.
  • GI transit recovery was significantly delayed in Ccr2 mice, with increased neutrophil-mediated immunopathology and impaired neuromuscular function.
  • Monocyte-derived macrophages acquired pro-resolving features, aiding inflammation resolution; enhancing their function ameliorated GI transit in Ccr2 mice.

Conclusions:

  • Monocyte-derived macrophages are critical for restoring intestinal homeostasis after surgical trauma.
  • Inappropriate monocyte targeting may exacerbate POI by increasing neutrophil-mediated immunopathology.
  • Future therapies should focus on enhancing macrophage physiological repair functions to improve POI outcomes.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
780
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.4K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
862
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
855
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K